The influence of the CRS-R score on functional outcome in patients with severe brain injury receiving early rehabilitation.

Coma Recovery Scale-Revised (CRS-R) Disorders of Consciousness (DoC) Neurological Early Rehabilitation; Prognosis; Functional Outcome

Journal

BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555

Informations de publication

Date de publication:
30 Jan 2021
Historique:
received: 28 01 2020
accepted: 19 01 2021
entrez: 30 1 2021
pubmed: 31 1 2021
medline: 2 4 2021
Statut: epublish

Résumé

The aim of the study was to determine the role of the Coma Recovery Scale-Revised (CRS-R) in the prediction of functional status at the end of neurological early rehabilitative treatment. Patients consecutively admitted to intensive or intermediate care units of a neurological rehabilitation center were enrolled in the study. Consciousness and functional status were assessed with the Coma Recovery Scale-Revised (CRS-R) and the Early Rehabilitation Barthel Index (ERBI), respectively. Both assessments were carried out weekly within the first month and at the end of early rehabilitation. Patient and clinical data were entered into a binary logistic regression model to predict functional status at discharge. 327 patients (112 females, 215 males) with a median age of 63 years (IQR = 53-75) and a median disease duration of 18 days (IQR = 12-28) were included. Most patients suffered from stroke (59 %), followed by traumatic brain injury (31 %), and hypoxic ischemic encephalopathy (10 %). Upon admission, 12 % were diagnosed as comatose, 31 % as unresponsive wakefulness syndrome (UWS), 35 % as minimally conscious state (MCS) and 22 % already emerged from MCS (eMCS). Of all patients undergoing complete early rehabilitative treatment (n = 180), 72 % showed improvements in level of consciousness (LOC). In this group, age, initial CRS-R score and gains in CRS-R score after four weeks independently predicted functional outcome at discharge. The study confirms the relevance of the CRS-R score for functional outcome prediction. High CRS-R scores and young age facilitate functional improvements and increase the probability to continue treatment in subsequent rehabilitation phases. Moreover, results indicate that recovery might occur over a period of time that extends beyond acute care.

Sections du résumé

BACKGROUND BACKGROUND
The aim of the study was to determine the role of the Coma Recovery Scale-Revised (CRS-R) in the prediction of functional status at the end of neurological early rehabilitative treatment.
METHODS METHODS
Patients consecutively admitted to intensive or intermediate care units of a neurological rehabilitation center were enrolled in the study. Consciousness and functional status were assessed with the Coma Recovery Scale-Revised (CRS-R) and the Early Rehabilitation Barthel Index (ERBI), respectively. Both assessments were carried out weekly within the first month and at the end of early rehabilitation. Patient and clinical data were entered into a binary logistic regression model to predict functional status at discharge.
RESULTS RESULTS
327 patients (112 females, 215 males) with a median age of 63 years (IQR = 53-75) and a median disease duration of 18 days (IQR = 12-28) were included. Most patients suffered from stroke (59 %), followed by traumatic brain injury (31 %), and hypoxic ischemic encephalopathy (10 %). Upon admission, 12 % were diagnosed as comatose, 31 % as unresponsive wakefulness syndrome (UWS), 35 % as minimally conscious state (MCS) and 22 % already emerged from MCS (eMCS). Of all patients undergoing complete early rehabilitative treatment (n = 180), 72 % showed improvements in level of consciousness (LOC). In this group, age, initial CRS-R score and gains in CRS-R score after four weeks independently predicted functional outcome at discharge.
CONCLUSIONS CONCLUSIONS
The study confirms the relevance of the CRS-R score for functional outcome prediction. High CRS-R scores and young age facilitate functional improvements and increase the probability to continue treatment in subsequent rehabilitation phases. Moreover, results indicate that recovery might occur over a period of time that extends beyond acute care.

Identifiants

pubmed: 33514337
doi: 10.1186/s12883-021-02063-5
pii: 10.1186/s12883-021-02063-5
pmc: PMC7847163
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

44

Références

Brain Inj. 2018;32(6):730-734
pubmed: 29482376
Arch Phys Med Rehabil. 2018 May;99(5):914-919
pubmed: 29428346
Arch Phys Med Rehabil. 1991 Oct;72(11):897-901
pubmed: 1929808
Front Neurol. 2018 Aug 14;9:665
pubmed: 30154755
Curr Pain Headache Rep. 2013 Nov;17(11):374
pubmed: 24078014
Rehabilitation (Stuttg). 2010 Feb;49(1):22-9
pubmed: 20178058
J Neurol. 2020 May;267(5):1245-1254
pubmed: 31773246
BMJ. 2019 May 22;365:l1778
pubmed: 31122927
Crit Rev Phys Rehabil Med. 2013;25(3-4):203-221
pubmed: 25541570
Brain Inj. 2018;32(1):72-77
pubmed: 29156989
BMC Med. 2010 Nov 01;8:68
pubmed: 21040571
Md State Med J. 1965 Feb;14:61-5
pubmed: 14258950
Neurology. 2013 Jan 29;80(5):464-70
pubmed: 23303855
Neuropsychol Rehabil. 2020 Mar;30(2):266-280
pubmed: 29661098
Ann Neurol. 2017 Jun;81(6):883-889
pubmed: 28543735
J Am Med Dir Assoc. 2015 Jan;16(1):85.e9-85.e14
pubmed: 25528282
Prog Brain Res. 2009;177:63-72
pubmed: 19818895
Dtsch Arztebl Int. 2010 Apr;107(16):286-92
pubmed: 20467554
BMC Neurol. 2014 Feb 21;14:34
pubmed: 24555811
Rehabilitation (Stuttg). 1995 May;34(2):69-73
pubmed: 7624593
BMC Res Notes. 2015 Jun 17;8:243
pubmed: 26081628
Neurology. 2002 Feb 12;58(3):349-53
pubmed: 11839831
BMC Neurol. 2019 Apr 18;19(1):68
pubmed: 30999877
Arch Phys Med Rehabil. 2013 Oct;94(10):1855-60
pubmed: 23732164
Biomed Res Int. 2017;2017:4719279
pubmed: 28900623
N Engl J Med. 2012 Mar 1;366(9):819-26
pubmed: 22375973
Brain Inj. 2014;28(9):1202-8
pubmed: 25099024
Arch Phys Med Rehabil. 2004 Dec;85(12):2020-9
pubmed: 15605342
Neurology. 2010 Jul 20;75(3):239-45
pubmed: 20554941
Rehabilitation (Stuttg). 2011 Dec;50(6):408-11
pubmed: 21626475
Lancet Neurol. 2008 Nov;7(11):1013-20
pubmed: 18835749
J Neurotrauma. 2017 Jan 15;34(2):535-539
pubmed: 27149928
Brain Inj. 2017;31(8):1019-1027
pubmed: 28534652
Arch Phys Med Rehabil. 2010 Dec;91(12):1795-813
pubmed: 21112421

Auteurs

Melanie Boltzmann (M)

Institute for Neurorehabilitative Research, Associated Institute of the Hannover Medical School, BDH-Clinic Hessisch Oldendorf, Hessisch Oldendorf, Germany. m.boltzmann@bdh-klinik-hessisch-oldendorf.de.

Simone B Schmidt (SB)

Institute for Neurorehabilitative Research, Associated Institute of the Hannover Medical School, BDH-Clinic Hessisch Oldendorf, Hessisch Oldendorf, Germany.

Christoph Gutenbrunner (C)

Department of Rehabilitation Medicine, Hannover Medical School, Hannover, Germany.

Joachim K Krauss (JK)

Department of Neurosurgery, Hannover Medical School, Hannover, Germany.

Martin Stangel (M)

Department of Neurology, Section of Clinical Neuroimmunology and Neurochemistry, Hannover Medical School, Hannover, Germany.

Günter U Höglinger (GU)

Department of Neurology, Hannover Medical School, Hannover, Germany.

Claus-W Wallesch (CW)

BDH-Clinic Elzach, Elzach, Germany.

Jens D Rollnik (JD)

Institute for Neurorehabilitative Research, Associated Institute of the Hannover Medical School, BDH-Clinic Hessisch Oldendorf, Hessisch Oldendorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH